Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Huddart

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pharmacogenetics and Genomics|January 24, 2019
PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamicsRachel Huddart, Russ B Altman, Teri E Klein
Pharmacogenetics and Genomics|September 18, 2018
PharmGKB summary: oxycodone pathway, pharmacokineticsRachel Huddart, Melissa Clarke, Russ B Altman, et al.
Seminars in Cutaneous Medicine and Surgery|May 4, 2019
Pharmacogenomics in dermatology: tools for understanding gene-drug associationsRoxana Daneshjou, Rachel Huddart, Teri E Klein, et al.
Clinical Pharmacology and Therapeutics|April 13, 2019
Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?Rachel Huddart, Katrin Sangkuhl, Michelle Whirl-Carrillo, et al.
Pharmacogenetics and Genomics|March 9, 2018
PharmGKB summary: clobazam pathway, pharmacokineticsRachel Huddart, J Steven Leeder, Russ B Altman, et al.
Clinical Pharmacology and Therapeutics|September 26, 2020
PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19Rachel Huddart, Michelle Whirl-Carrillo, Russ B Altman, et al.
Clinical Pharmacology and Therapeutics|July 3, 2021
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized MedicineMichelle Whirl-Carrillo, Rachel Huddart, Li Gong, et al.
Pharmacogenetics and Genomics|February 1, 2022
PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reactionElise Miller, Charles Norwood, Jason B Giles, et al.
Pharmacological Research|May 15, 2020
Response to: Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortiaRachel Huddart, Li Gong, Katrin Sangkuhl, et al.
Pharmacogenetics and Genomics|December 19, 2019
PharmGKB summary: sertraline pathway, pharmacokineticsRachel Huddart, J Kevin Hicks, Laura B Ramsey, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmacogenetics and Genomics|January 24, 2019
PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamicsRachel Huddart, Russ B Altman, Teri E Klein
Pharmacogenetics and Genomics|September 18, 2018
PharmGKB summary: oxycodone pathway, pharmacokineticsRachel Huddart, Melissa Clarke, Russ B Altman, et al.
Seminars in Cutaneous Medicine and Surgery|May 4, 2019
Pharmacogenomics in dermatology: tools for understanding gene-drug associationsRoxana Daneshjou, Rachel Huddart, Teri E Klein, et al.
Clinical Pharmacology and Therapeutics|April 13, 2019
Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?Rachel Huddart, Katrin Sangkuhl, Michelle Whirl-Carrillo, et al.
Pharmacogenetics and Genomics|March 9, 2018
PharmGKB summary: clobazam pathway, pharmacokineticsRachel Huddart, J Steven Leeder, Russ B Altman, et al.
Clinical Pharmacology and Therapeutics|September 26, 2020
PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19Rachel Huddart, Michelle Whirl-Carrillo, Russ B Altman, et al.
Clinical Pharmacology and Therapeutics|July 3, 2021
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized MedicineMichelle Whirl-Carrillo, Rachel Huddart, Li Gong, et al.
Pharmacogenetics and Genomics|February 1, 2022
PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reactionElise Miller, Charles Norwood, Jason B Giles, et al.
Pharmacological Research|May 15, 2020
Response to: Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortiaRachel Huddart, Li Gong, Katrin Sangkuhl, et al.
Pharmacogenetics and Genomics|December 19, 2019
PharmGKB summary: sertraline pathway, pharmacokineticsRachel Huddart, J Kevin Hicks, Laura B Ramsey, et al.
Pageof 2